Using a seed-amplification assay (SAA) and ultrasensitive RT-QuIC, the study evaluated the prion-like seeding activity of pathological tau in skin samples from cadavers with confirmed tauopathies, comparing the results to healthy controls. Here, MAPT is linked to tauopathy.